Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607048 · ClinicalTrials.gov registry record · Phase 1
Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors
A Phase 1 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT00607048 is a Phase 1 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 34 participants.
The verdict
NCT00607048, a Phase 1 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a dose-finding study; therefore, there is no hypothesis testing
Interventions
- DRUG Paclitaxel + Carboplatin + CP-870,893
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607048
The ClinicalTrials.gov registry entry for NCT00607048 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paclitaxel + Carboplatin + CP-870,893 is the first listed.
NCT00607048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00607048 about?
NCT00607048 is a clinical study titled "Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors". This is a dose-finding study; therefore, there is no hypothesis testing
What is the current status of trial NCT00607048?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2007-11. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00607048?
The interventions under investigation include: Paclitaxel + Carboplatin + CP-870,893 (DRUG).
Who is sponsoring clinical trial NCT00607048?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.